يحاول ذهب - حر
Infosys, Wipro beat Street, differ on AI
October 17, 2025
|Mint Mumbai
Both raise headcount; HI revenue up for Infosys, down for Wipro
Infosys Ltd put up a better-than-expected show in the September quarter and raised the lower end of its full-year guidance, even as it cautiously watched a turbulent world.
While cross-city rival Wipro Ltd too beat the Street, its performance paled in comparison, growing at a slower pace and profitability declined.
Infosys, India's second-largest IT services firm, ended the September quarter with $5.08 billion in revenue, up 2.66% from the June quarter and 3.77% from the previous year. More than half of the gains came from banks and financial institutions, the company's biggest client base.
The Q2 performance of Wipro, India's fourth-largest IT firm, was relatively sedate. Its revenue was $2.6 billion, up 0.65% sequentially and down 2.1% on a yearly basis. Like Infosys, much of its business was pulled up by banks, while revenue from most other verticals declined.
Banks make up slightly more than a third of Wipro’s business.
This wraps up earnings for India’s five largest IT companies, with the biggest—Tata Consultancy Services— reporting the weakest performance and third-largest, HCL Technologies Ltd, proving to be an outlier.
TCS, HCL Tech and Tech Mahindra Ltd ended the second quarter with revenues of $7.47 billion, $3.64 billion and $1.59 billion, up 0.61%, 2.79% and 1.41% on a sequential basis, respectively.
Three of the Big Five grew revenues in the first half of the fiscal year. The rest didn’t.
Revenue divergence
While revenues at Infosys, HCL Tech and Tech Mahindra grew 4.3%, 5.6% and 0.1% to $10 billion, $7.19 billion and $3.15 billion respectively during the first half, TCS and Wipro saw revenue decline—down 1.9% to $14.89 billion for TCS and 1.8% to $5.19 billion for Wipro.
This raises a warning sign for the two companies, since the first half is traditionally stronger for homegrown IT services firms due to more billing days and fewer holidays.
هذه القصة من طبعة October 17, 2025 من Mint Mumbai.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Mumbai
Mint Mumbai
JSW Steel eyes strong H2 on demand, policy boost
After reporting robust numbers for the second quarter despite a challenging global environment, JSW Steel said it expects a strong second half for the company on the back of 8-9% growth in domestic demand for steel in FY26.
2 mins
October 18, 2025
Mint Mumbai
Govt plans Golden Quadrilateral 2.0 to expand road grid
The Union government is planning a sequel to the Golden Quadrilateral network of national highways, introducing high-speed expressways linking India's major economic centres, according to two officials aware of the matter.
2 mins
October 18, 2025

Mint Mumbai
RIL Q2: Profit surges 16% as all engines gain steam
All of its key businesses—O2C, telecom and retail—saw marginal improvements
3 mins
October 18, 2025
Mint Mumbai
Gift with intention
Communication isn't just about exchanging information; it's about exchanging information that makes us understand, comprehend and feel for one another.
1 mins
October 18, 2025

Mint Mumbai
Food delivery growth cushions Blinkit losses for Eternal in Q2
Eternal Ltd (formerly known as Zomato) posted amixed bag performance in the September quarter (Q2FY26).
2 mins
October 18, 2025

Mint Mumbai
In the dark about light pollution
Beset as we are with many kinds of pollution, we barely pay attention to light pollution and ignore the risks it poses
5 mins
October 18, 2025

Mint Mumbai
12 states, UTs support e-bus payment plan
PM E-bus Sewa PSM scheme plans to build confidence in e-bus makers
2 mins
October 18, 2025
Mint Mumbai
Govt plans highway network to expand road grid
The officials did not disclose the planned length of the proposed high-speed expressways or the investment.
1 min
October 18, 2025
Mint Mumbai
SC allows Natco to sell generic of Roche drug until case ends
The Supreme Court on Friday rejected Swiss pharmaceutical giant F. Hoffmann-La Roche AG's (Roche) pleaseeking that Natco Pharma Ltd berestricted from selling the generic version of its lifesaving spinal muscular atrophy (SMA) drug, Risdiplam, in India until the conclusion of the case.
2 mins
October 18, 2025

Mint Mumbai
Dixon meets revenue goal in Q2, bets on components
Topline grows 33% on year to ₹14,855 cr, unsold goods from Q1 drive profits in Sep quarter
3 mins
October 18, 2025
Listen
Translate
Change font size